You just read:

Central European Society for Anticancer Drug Research Announces Start of Enrollment in First Randomized Trial of Pharmacokinetic-Guided Dose Adjustment of Paclitaxel in Non-Small Cell Lung Cancer

News provided by

Saladax Biomedical, Inc.

Apr 26, 2011, 10:17 ET